Alzamend Neuro, Inc.ALZNNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank89
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
20.58%
↑ 103% vs avg
Percentile
P89
Within normal range
Streak
3 yr
Consecutive growthAccelerating
Average
-784.78%
Historical baseline
PeriodValue
202520.58%
20247.32%
2023-34.91%
2022-143.88%
2021-15.61%
2020-124.43%
201949.06%
2018-44.82%
2017-7561.12%
20160.00%